ClinicalTrialsFinder

High Risk Cardiovascular Disease Clinical Trials in Altenburg

1 recruitingAltenburg, Germany

Showing 1–1 of 1 trials

Recruiting
Phase 3

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

HypertensionHigh Risk Cardiovascular DiseaseHigh Cardiovascular Risk
Alnylam Pharmaceuticals11,000 enrolled597 locationsNCT07181109